NHLBI Obesity, Nutrition, and Physical Activity (ONPA) Seminar Series: A New Era in Pediatric Obesity Treatment: GLP-1RAs, Precision Medicine, and Defining Success Beyond Weight Loss Alone

Review the changing treatment landscape for childhood obesity, including GLP-1 receptor agonists, other medicines and bariatric surgery. Clinical trials and real-world studies examine differences in treatment response, physiological phenotyping and the needs of adolescents and young people with developmental disabilities. The talk considers body composition, nutrition, mental health, long-term benefit, access and personalised care beyond weight change alone.